PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
31421166-9	2019	Further investigation of grp94 inhibitors may lead to a new class of broad-spectrum anti-flaviviral medications.	flaviviral	89-99	heat shock protein 90 beta family member 1	Homo sapiens	25-30
34741027-1	2021	To understand how RNA dynamics is regulated and connected to its function, we investigate the folding, conformational dynamics and robustness of Xrn1 resistance of a set of flaviviral xrRNAs using SAXS, smFRET and in vitro enzymatic assays.	flaviviral	173-183	5'-3' exoribonuclease 1	Homo sapiens	145-149
35203378-6	2022	This work highlights the NS5-NS3 binding interface as a viable target for the development of anti-flaviviral therapeutics.	flaviviral	98-108	Raf-1 proto-oncogene, serine/threonine kinase	Homo sapiens	25-28
35203378-6	2022	This work highlights the NS5-NS3 binding interface as a viable target for the development of anti-flaviviral therapeutics.	flaviviral	98-108	KRAS proto-oncogene, GTPase	Homo sapiens	29-32
32950301-3	2020	The flaviviral CP is the smallest structural protein and forms a homodimer by antiparallel alpha-helixes.	flaviviral	4-14	ceruloplasmin	Homo sapiens	15-17
22615830-3	2012	Being indispensable for flaviviral replication, the NS2B-NS3 protease is a promising target for design of anti-flaviviral inhibitors.	flaviviral	24-34	KRAS proto-oncogene, GTPase	Homo sapiens	57-60
22615830-3	2012	Being indispensable for flaviviral replication, the NS2B-NS3 protease is a promising target for design of anti-flaviviral inhibitors.	flaviviral	111-121	KRAS proto-oncogene, GTPase	Homo sapiens	57-60
21143108-13	2011	Peptide inhibitors against the highly conserved NS2B and NS3 proteases are attractive as pan-flaviviral drug candidates.	flaviviral	93-103	KRAS proto-oncogene, GTPase	Homo sapiens	57-60
22102908-0	2011	Ago-2-mediated slicer activity is essential for anti-flaviviral efficacy of RNAi.	flaviviral	53-63	argonaute RISC catalytic component 2	Homo sapiens	0-5